PetPace, the maker of a collar-based vital-signs monitor, has launched an epilepsy study in partnership with universities and veterinary hospitals in the United States, Canada, the United Kingdom and Israel. The researchers hope to use collected data such as pulse and respiratory rate, temperature, activity patterns, body posture and heart rate variability to predict and detect seizures in dogs. The lead investigator is Bob Murtaugh, DVM, MS, Dipl. ACVIM, Dipl. ACVECC, the chief medical officer at hospital management company Pathway Partners. “Understanding the true prevalence of seizure activity is invaluable in our attempts to effectively manage epilepsy in dogs,” Dr. Murtaugh said. “The introduction of the PetPace technology will allow us, for the first time in veterinary medicine, to attempt just that: know exactly when, in real time, and for how long each patient has a seizure.” PetPace is headquartered in Burlington, Mass. Originally published in the May 2016 issue of Veterinary Practice News. Did you enjoy this article? Then subscribe today!
